Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
BIND Therapeutics
4241
BIND Therapeutics
Health Care
Technology
Biotechnology
BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics.
Suggest edits
Founded
2006
Raised
$37.9M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Biogen
Money Mover
HubSpot
Formlabs
Akamai
General Catalyst
Companies in the same industry
Valneva SE
Semma Therapeutics
Quantapore Inc.
Patara Pharma, LLC
Premier Research
Neon Therapeutics
Imprimis Pharma
HepaRegeniX
Hexafly
Bioverativ
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Add round
13 Feb
2012
$25,500,000
Venture capital (Series D)
RUSNANO
29 Jun
2010
$12,400,000
Venture capital (Series C)
Endeavour Vision
,
Flagship Ventures
,
Polaris Partners
,
+2
